These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 9105548

  • 21. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
    Yamada Y, Endo M, Kohno M, Otsuka M, Takaiti O.
    Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
    [Abstract] [Full Text] [Related]

  • 22. [Study on metabolism of pyridonecarboxylic acid II. Determination of metabolites of (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)- 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluenesulfonate hydrate (T-3262) in blood, urine, bile, and feces].
    Tai M, Sakai H, Nitta J, Hayakawa H, Sugimoto Y, Hayashi K, Maeda T.
    Jpn J Antibiot; 1989 Apr; 42(4):876-86. PubMed ID: 2769940
    [Abstract] [Full Text] [Related]

  • 23. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE, Dean BJ, Doss GA, Wang Z, Hop CE, Anari R, Finke PE, Robichaud AJ, Zhang M, Wang B, Strauss JR, Cunningham PK, Feeney WP, Franklin RB, Baillie TA, Chiu SH.
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [Abstract] [Full Text] [Related]

  • 24. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Yoshida K, Itogawa A, Tagawa M, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [Abstract] [Full Text] [Related]

  • 25. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
    Park YH, Jung BH, Chung BC, Park J, Mitoma C.
    Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 3rd communication: metabolism in rats, rabbits, dogs and monkeys, and effects on hepatic drug-metabolizing enzyme activities in rats after repeated administration.
    Mukai H, Watanabe S, Morino A.
    Arzneimittelforschung; 1999 Jul; 49(7):612-7. PubMed ID: 10442210
    [Abstract] [Full Text] [Related]

  • 27. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C, Chen W, Rossulek M, Johnson K, Zhang C, O'Connell T, Potchoiba M, Dalvie D.
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [Abstract] [Full Text] [Related]

  • 28. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM, D'Souza RA, Jordan AC, King CD, Smith SM, Phillips PJ, McCormick AD, Roberts DW.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):1065-77. PubMed ID: 17030109
    [Abstract] [Full Text] [Related]

  • 29. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C, Johnson KA, Schroeder CM, Potchoiba MJ.
    Drug Metab Dispos; 2008 Sep 19; 36(9):1753-69. PubMed ID: 18515329
    [Abstract] [Full Text] [Related]

  • 30. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
    Cheng H, Stuhler JD, Dorrbecker BR, Gordon WP.
    Drug Metab Dispos; 1991 Sep 19; 19(1):212-7. PubMed ID: 1673401
    [Abstract] [Full Text] [Related]

  • 31. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C, Kamel A, Gummerus J, Wilner K.
    Drug Metab Dispos; 1997 Jul 19; 25(7):863-72. PubMed ID: 9224781
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
    Tachibana M, Tanaka M, Mitsugi K, Jin Y, Takaichi M, Okazaki O.
    Arzneimittelforschung; 2004 Jul 19; 54(12):898-905. PubMed ID: 15646375
    [Abstract] [Full Text] [Related]

  • 33. Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
    Yoshida T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1993 Apr 19; 37(4):793-800. PubMed ID: 8388199
    [Abstract] [Full Text] [Related]

  • 34. A new tricyclic fluoroquinolone, rufloxacin (MF-934), with interesting antibacterial and pharmacokinetic characteristics.
    Segre G, Cerretani D, Cerri D, Moltoni L.
    Drugs Exp Clin Res; 1988 Apr 19; 14(12):747-54. PubMed ID: 3253051
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs.
    Hirota T, Nakamura A, Sugihara K, Morino A.
    Arzneimittelforschung; 1997 Feb 19; 47(2):175-81. PubMed ID: 9079237
    [Abstract] [Full Text] [Related]

  • 36. LD50 value, phototoxicity and convulsion induction test of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acid hemihydrate in laboratory animals.
    Shimoda K, Akahane K, Nomura M, Kato M.
    Arzneimittelforschung; 1996 Jun 19; 46(6):625-8. PubMed ID: 8767355
    [Abstract] [Full Text] [Related]

  • 37. [Study on metabolism of pyridonecarboxylic acid. I. Isolation and identification of metabolites of (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluenesulfonate hydrate (T-3262) in urine].
    Tai M, Konishi Y, Sugimoto Y, Demachi K, Maeda T.
    Jpn J Antibiot; 1989 Apr 19; 42(4):868-75. PubMed ID: 2769939
    [Abstract] [Full Text] [Related]

  • 38. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW.
    Drug Metab Dispos; 1997 Apr 19; 25(4):489-501. PubMed ID: 9107549
    [Abstract] [Full Text] [Related]

  • 39. [Renal toxicity of prulifloxacin (NM441) in rats].
    Kawaminami A, Tawaratani T, Ishibashi S, Oka T, Matsuyama S, Kakemi K, Iwakura K, Sumi N, Shindo Y.
    J Toxicol Sci; 1996 Jun 19; 21 Suppl 1():267-76. PubMed ID: 8709167
    [Abstract] [Full Text] [Related]

  • 40. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS, Joseph DP, Dinallo RM, Davidson WC, Keirns JJ, Hattox SE.
    Drug Metab Dispos; 1999 Dec 19; 27(12):1434-47. PubMed ID: 10570025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.